Option Care Health (OPCH) Expected to Announce Quarterly Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) will likely be issuing its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Option Care Health Trading Up 0.2 %

NASDAQ:OPCH opened at $32.08 on Tuesday. Option Care Health has a one year low of $21.39 and a one year high of $34.17. The business has a fifty day moving average price of $27.89 and a 200-day moving average price of $27.98. The firm has a market capitalization of $5.46 billion, a price-to-earnings ratio of 26.96, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Analysts Set New Price Targets

A number of brokerages have commented on OPCH. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.